Introduction: Meningococcal infection is a major cause of morbidity and mortality worldwide.
Infection with Neisseria meningitidis is most common in young children, teenagers and …

Invasive meningococcal disease (IMD) is a life-threatening, unpredictable condition.
Vaccines are available against 5 of the 6 meningococcal serogroups (Men) accounting for …

Serogroup X meningococci (Nm X) historically have caused sporadic and clustered
meningitis cases in sub-Saharan Africa. To study recent Nm X epidemiology, we analyzed …

Background. Vaccination with meningococcal serogroup C (MenC) conjugate (MCC)
polysaccharide vaccines led to a substantial decline in MenC disease in the vaccinated and …

Notwithstanding different meningococcal serogroups have changed their distribution and
their impact in different age classes over time, N. meningitidis' invasive diseases are a major …

Meningococcal disease is a life-threatening illness occurring worldwide with incidence rates
varying from 1 to 1000 cases per 100000. The causative organism, Neisseria meningitidis, is …

A number of countries now include meningococcal vaccines in their routine immunization
programs. This review focuses on different approaches to including meningococcal vaccines …

Colonization of the human nasopharyngeal tract by the bacterium Neisseria meningitidis is
usually asymptomatic, but life-threatening meningococcal disease with a clinical …

Africa historically has had the highest incidence of meningococcal disease with high
endemic rates and periodic epidemics. The meningitis belt, a region of sub-Saharan Africa …

Glycoconjugate vaccines have been proven safe and effective against various diseases in
children. Although these vaccines have a history of effectiveness, there are still many …